Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;114(1):10-9.
doi: 10.1016/j.ophtha.2006.08.031. Epub 2006 Nov 7.

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

Ocular Hypertension Treatment Study Group  1 ; European Glaucoma Prevention Study Group; Mae O Gordon, Valter Torri, Stefano Miglior, Julia A Beiser, Irene Floriani, J Philip Miller, Feng Gao, Ingrid Adamsons, Davide Poli, Ralph B D'Agostino, Michael A Kass
Affiliations

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

Ocular Hypertension Treatment Study Group et al. Ophthalmology. 2007 Jan.

Abstract

Objective: To test the validity and generalizability of the Ocular Hypertension Treatment Study (OHTS) prediction model for the development of primary open-angle glaucoma (POAG) in a large independent sample of untreated ocular hypertensive individuals and to develop a quantitative calculator to estimate the 5-year risk that an individual with ocular hypertension will develop POAG.

Design: A prediction model was developed from the observation group of the OHTS and then tested on the placebo group of the European Glaucoma Prevention Study (EGPS) using a z statistic to compare hazard ratios, a c statistic for discrimination, and a calibration chi2 for systematic overestimation/underestimation of predicted risk. The 2 study samples were pooled to increase precision and generalizability of a 5-year predictive model for developing POAG.

Participants: The OHTS observation group (n = 819; 6.6 years' median follow-up) and EGPS placebo group (n = 500; 4.8 years' median follow-up).

Testing: Data were collected on demographic characteristics, medical history, ocular examination visual fields (VFs), and optic disc photographs.

Main outcome measure: Development of reproducible VF abnormality or optic disc progression as determined by masked readers and attributed to POAG by a masked end point committee.

Results: The same predictors for the development of POAG were identified independently in both the OHTS observation group and the EGPS placebo group-baseline age, intraocular pressure, central corneal thickness, vertical cup-to-disc ratio, and Humphrey VF pattern standard deviation. The pooled multivariate model for the development of POAG had good discrimination (c statistic, 0.74) and accurate estimation of POAG risk (calibration chi2, 7.05).

Conclusions: The OHTS prediction model was validated in the EGPS placebo group. A calculator to estimate the 5-year risk of developing POAG, based on the pooled OHTS-EGPS predictive model, has high precision and will be useful for clinicians and patients in deciding the frequency of tests and examinations during follow-up and advisability of initiating preventive treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
See this image and copyright information in PMC

References

    1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389–93. - PMC - PubMed
    1. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412–7. - PubMed
    1. Kahn HA, Moorehead HB. Statistics on Blindness in the Model Reporting Area 1969–70. Washington, D.C.: US Department of Health, Education and Welfare; 1973. pp. 73–427. Publication no. NIH 73-427.
    1. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83–91. - PubMed
    1. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology. 2001;108:1751–6. - PubMed

Publication types